ALAB Company Profile and Key Details

ALAB has shown sold momentum, gaining 6.48% over the past week and 14.99% over the past quarter, though year-to-date performance is up 10.45%. Short-term trend indicators are mixed aligned (SMA20 -13.26%, SMA50 -20.91%, SMA200 -17.78%). The stock’s 14-day RSI is 38.45 (weak momentum), while the ATR of 12.02 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -52.58% below its high and over 164.55% above its low. Average 10-day trading volume of 6.56 million shares is slightly above the 3-month average of 5.22 million, indicating heightened recent market interest.

Wall Street analysts project EPS growth of 36.22% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 20 Strong Buy ratings, 13 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $275.00 to $110.00. The high target offers 58.0% upside. The low target suggests -36.8% downside. The mean target is $190.00. This offers 9.16% upside. Astera Labs, Inc. Common Stock earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 04, 2025, missed forecasts by 25.64%. The prior quarter beat by 35.76%. Over the last six quarters, Apple has recorded several small beats. These include 18.18% in August 06, 2024.

Astera Labs, Inc. Common Stock last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$6.15. This means the shares are trading below this model’s fair value.

Astera Labs, Inc. Common Stock has 170.21 million shares outstanding. The public float is 140.92 million shares, elevated short interest at 10.71% of float. This equals 13.52 million shares. The short ratio is 2.86 days. Institutional investors hold 86.62% of the float. Insiders own 11.4%. Mohan Jitendra holds 4.41 million shares, Gajendra Sanjay has 1.53 million shares and ALBA MANUEL has 319.86 thousand shares. Over the past six months, insider transactions show net selling. They sold 123.02 thousand shares across 18 transactions.

Astera Labs, Inc. Common Stock (NASDAQ:ALAB) shares are up 10.45% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Astera Labs, Inc. Common Stock trading at a premium to the broader market with a P/E of 132.75. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $170.80, suggesting -1.87% downside. Our AI forecast model points to short-term strength (1.57% over two weeks), a medium-term rise (101.56% over three months), and a longer-term gain (35.52% over one year), with expected trading ranges indicating moderate volatility.

Astera Labs, Inc. Common Stock (NASDAQ:ALAB) closed at $174.05 USD, gaining $3.24 (1.90%) from the previous close of $170.81. The stock is currently mid-range between its 52-week high and low $52.56 and $262.90. With a market capitalization of about $29.63 billion, Astera Labs, Inc. Common Stock is classified as a large-cap and shows higher-than-market volatility (beta ~1.79). Key stats such as the average daily volume over the past year has been around 5.29 million shares, in line with its 52-week average. Headquartered in Santa Clara, CA, Astera Labs, Inc. Common Stock operates in the Technology sector and the Semiconductors industry. Led by CEO Jitendra Mohan, the company employs approximately 440 people and listed since March 20, 2024. Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure.

Our AI price prediction model suggests that Astera Labs, Inc. Common Stock stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 1.57%, with price expected at $176.78 by May 01, 2026, within a range of $160.51 to $192.76 3-Month Outlook: Projected rise of 101.56%, reaching $350.82 by July 16, 2026, with a range of $345.37 to $358.23. 1-Year Outlook: Projected gain of 35.52%, with price at $235.87 by April 16, 2027, within a range of $224.33 to $251.61.

Astera Labs, Inc. Common Stock trades at a P/E ratio of 132.75, slightly above the S&P 500 average, with a price-to-sales ratio of 34.27 and a price-to-book ratio of 21.33 reflecting a rich premium to book value. The P/FCF stands at 103.68, also above market averages. Compared to sector medians, Astera Labs, Inc. Common Stock P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.